Is it over?

Funny thing when a stock comes under a short attack it’s next to impossible to determine when the attack is over. As we reported Dexcom has come under attack, got hit pretty hard but has rallied recently. So the question becomes is the attack over or is this just a lull before the next salvo. Honestly, we have no idea but here is what we do know-

1. Our long-term outlook for Dexcom has not changed we continue to see a very bright future for the company.

2. As so often happens short attacks result . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

© 2005 - 2020 Diabetic Investor, Inc., all rights reserved. Unless expressly permitted under your written license agreement, you are not authorized to forward or to otherwise copy our newsletter, or any portion thereof, by electronic means or otherwise. 17 U.S.C. §504 provides for statutory damages of up to $150,000 per infringement of a copyright and additional damages.